Faron Pharmaceuticals Oy (FARN) Competitors GBX 172.70 -4.80 (-2.70%) As of 04:07 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock FARN vs. ERGO, SLN, PRTC, HZD, AVCT, VRP, ARIX, CIR, BVXP, and 4BBShould you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Avacta Group (AVCT), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Circassia Group (CIR), Bioventix (BVXP), and 4basebio (4BB). These companies are all part of the "biotechnology" industry. Faron Pharmaceuticals Oy vs. Its Competitors Ergomed Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Avacta Group Verona Pharma plc (VRP.L) Arix Bioscience Circassia Group Bioventix 4basebio Faron Pharmaceuticals Oy (LON:FARN) and Ergomed (LON:ERGO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations. Do institutionals and insiders have more ownership in FARN or ERGO? 2.9% of Faron Pharmaceuticals Oy shares are owned by institutional investors. Comparatively, 71.1% of Ergomed shares are owned by institutional investors. 4.1% of Faron Pharmaceuticals Oy shares are owned by company insiders. Comparatively, 18.2% of Ergomed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, FARN or ERGO? Faron Pharmaceuticals Oy has a beta of 0.36, meaning that its share price is 64% less volatile than the S&P 500. Comparatively, Ergomed has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Is FARN or ERGO more profitable? Ergomed has a net margin of 9.87% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. Ergomed's return on equity of 18.08% beat Faron Pharmaceuticals Oy's return on equity.Company Net Margins Return on Equity Return on Assets Faron Pharmaceuticals OyN/A 0.46% -70.00% Ergomed 9.87%18.08%10.16% Which has stronger valuation & earnings, FARN or ERGO? Ergomed has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFaron Pharmaceuticals OyN/AN/A-£60.23M-£0.27-639.63Ergomed£152.09M0.00£15M£0.29N/A Does the media refer more to FARN or ERGO? In the previous week, Faron Pharmaceuticals Oy had 1 more articles in the media than Ergomed. MarketBeat recorded 1 mentions for Faron Pharmaceuticals Oy and 0 mentions for Ergomed. Faron Pharmaceuticals Oy's average media sentiment score of 0.00 equaled Ergomed'saverage media sentiment score. Company Overall Sentiment Faron Pharmaceuticals Oy Neutral Ergomed Neutral SummaryErgomed beats Faron Pharmaceuticals Oy on 10 of the 11 factors compared between the two stocks. Get Faron Pharmaceuticals Oy News Delivered to You Automatically Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FARN vs. The Competition Export to ExcelMetricFaron Pharmaceuticals OyBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£193.35M£223.11M£6.04B£2.60BDividend YieldN/A3.81%5.73%5.32%P/E Ratio-639.6399.6485.104,425.56Price / SalesN/A5,775.70556.60101,390.64Price / Cash20.0013.1937.5727.90Price / Book0.0999.4912.347.72Net Income-£60.23M-£90.99M£3.32B£5.89B7 Day Performance1.53%-0.93%-1.33%0.26%1 Month Performance-11.44%4.24%8.12%2.15%1 Year Performance-14.50%688.51%73.80%142.49% Faron Pharmaceuticals Oy Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FARNFaron Pharmaceuticals OyN/AGBX 172.70-2.7%N/A-14.6%£193.35MN/A-639.6334News CoveragePositive NewsERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech HealthN/AGBX 134-0.6%GBX 455+239.6%-13.8%£323.86M£6.17M788.24300HZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416AVCTAvacta Group2.3997 of 5 starsGBX 71.36-0.9%GBX 99+38.7%+6.3%£291.32M£113K-406.58120News CoverageAnalyst ForecastVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,425+1.0%N/A-38.9%£126.71M£13.66M1,637.1912High Trading Volume4BB4basebio1.4857 of 5 starsGBX 764.45-1.4%GBX 1,600+109.3%-46.4%£118.38M£1.78M-772.17101 Related Companies and Tools Related Companies Ergomed Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Avacta Group Alternatives Verona Pharma plc (VRP.L) Alternatives Arix Bioscience Alternatives Circassia Group Alternatives Bioventix Alternatives 4basebio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FARN) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
